Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.
Saved in:
| Title: | Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials. |
|---|---|
| Authors: | Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kalliolias GD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Xu CR; Sanofi, Bridgewater, New Jersey, USA., Harel S; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Lai CH; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Zheng W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2022 Feb; Vol. 15 (2), pp. 384-395. Date of Electronic Publication: 2021 Sep 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
